Donor Screening - Serology Solutions

Bringing safety, reliability and efficiency to donor screening

Roche Diagnostics serology assays and instruments can be used to perform a broad range of immunoassays and offer various options to suit your throughput needs.

Roche Elecsys® assays include highly specific and sensitive serology tests to detect infectious diseases. The test is based on ECL (ElectroChemiLuminescence) technology and delivers reliable results.^1-10 All serology screening assays detect the major viral genotypes and variants found worldwide. They show very high seroconversion sensitivity, and their very high specificity and clear cut-off separation of positive and negative results reduces the need for retesting.^1-10

View all products

Ensuring patient safety during blood transfusions

Comprehensive variant coverage to ensure reliable detection of infectious samples^1-10

Excellent sensitivity to allow for detection of early infections^1-10

Automated sample handling reduces risk of manual handling errors

Improving efficiency by automating screening tests

Decrease the need for retesting and minimize loss of donations due to high specificity of Elecsys® assays^1-10

Allow your staff to focus on important tasks by achieving up to 5 hours of walkaway time¹²

Supporting a consistent and reliable blood supply

Optimized uptime (>99,2%)¹¹of cobas® instruments that ensure the timely release of blood products

Validated workflows for cross-contamination compliance¹³

Assurance in service with skilled local Roche support teams available when you need them

Explore Roche serology assays and analyzers for donor screening

A comprehensive state-of-the-art portfolio to deliver an integrated solution on the same serology instrument.

Donor screening assay

Elecsys® HIV Duo*
Elecsys® HIV combi PT
Elecsys® Anti-HCV II
Elecsys® HBsAg II
Elecsys® Anti-HBc II
Elecsys® Anti-HBs II
Elecsys® HTLV-I/II
Elecsys® Syphilis
Elecsys® CMV IgG
Elecsys® Chagas

Additional serology assays

Elecsys® Anti-HAV
Elecsys® Anti-HAV-IgM
Elecsys® Anti-HBc IgM
Elecsys® Anti-HBe
Elecsys® CMV IgG avidity
Elecsys® CMV IgM
Elecsys® EBV**
Elecsys® HBeAg
Elecsys® HBsAg II quant II
Elecsys® HCV Duo*^/**

Elecsys® HIV-Ag
Elecsys® HSV-1 IgG
Elecsys® HSV-2 IgG
Elecsys® Rubella
Elecsys® Rubella IgM
Elecsys® Toxo IgG
Elecsys® Toxo IgG avidity
Elecsys® Toxo IgM
Elecsys® Zika IgG

*For cobas e801; **In development

Note: Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio in addition is not available in USA, Canada and Philippines.

Which serology solution best fits your needs?

cobas e 801 module

Available for the cobas® 8000 modular analyzer series
High to extra high volume workload
Throughput of up to 300 tests per hour per module
Modular and scalable to four analytical modules
Continuous reagent cassette loading/unloading during operation

cobas e 411 analyzer

Available for the cobas® 4000 analyzer series
Low volume workload
Throughput of up to 75 tests per hour

Designed to work together

Explore Roche's donor screening solutions

Nucleic Acid Testing

Roche offers a comprehensive portfolio of NAT solutions, including instruments and assays developed using high-performance real-time PCR technology.

Easily integrated into pre- and post-analytic solutions, they enable greater overall workflow efficiency.

Healthcare Consulting Services

Our consultancy solutions help increase your productivity and turnaround time by working with you to find the optimal system configuration, automation and workflow.

Donor Screening

At Roche, we are dedicated to help you save patients’ lives by delivering safe, reliable and efficient blood safety solutions, today and in the future.

Roche offers a complete solution for blood and plasma screening tailored to your needs and designed to work together for maximum efficiency.

...

Products of the Roche Blood Safety Solutions portfolio are not commercially available in all regions. Please contact your local Roche representative regarding availability. Serology portfolio in addition is not available in USA, Canada and Philippines.

References

Mühlbacher, A., et al. (2013). Med Microbiol Immunol 202, 77–86.
Mühlbacher, A., et al. (2008). Med Microbiol Immunol 197, 55–64.
Esteban, J., et al. (2013). J Med Virol 85, 1362–1368.
Ly, T.D., et al. (2012). J Clin Virol 55, 121–127.
Louisirirotchanakul, S., et al. (2010). J Med Virol 82, 755–762.
Jia, J.D., et al. (2009). Med Microbiol Immunol 198, 263–269.
Laperche, S., et al. (2017). J. Clin. Microbiol 55, 2180-2187.
Kremastinou, J., et al. (2016). J. Clin. Microbiol 54, 2330-2336.
Sommese, L., et al. (2014). Scandinavian Journal of Infectious Diseases 46, 660–664.
Schmidt, M., et al. (2015). Vox Sanguinis 109, 114-21.
Data on file. Roche Diagnostics International Ltd.
Data on file. Roche Diagnostics International Ltd.
Roche. (2016). Declaration of Serology and NAT testing compliance. | Iordanoaia, N., et al. (2016 September). Cross-contamination Compliance of cobas p 612 pre-analytical system in use with cobas® 6800/8800 Systems. Poster presented at ISBT, Dubai, UAE.

Donor Screening – Serology Solutions